Skip to main content
Fig. 2 | Alzheimer's Research & Therapy

Fig. 2

From: Correction to: Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer’s disease, but not in cerebral amyloid angiopathy

Fig. 2

A ROC analysis showed moderately high accuracy levels for discrimination of aMCI from control in the Nijmegen aMCI patients and controls (gray line) and the Barcelona aMCI patients and controls (black line). B ROC analysis showed consistently high accuracy levels for discrimination of AD from control in the Nijmegen AD patients and controls (gray line) and the Barcelona AD patients and controls (black line). Abbreviations: AD, Alzheimer’s disease; AUC area under the curve. The Barcelona cohort serves as a validation cohort

Back to article page

Alzheimer's Research & Therapy

ISSN: 1758-9193